SITAVIB M 500 SITAGLIPTIN PHOSPHATE 50mg. IP + METFORMIN 500mg. IP

Sitavib M 500 tablets combine Sitagliptin Phosphate 50mg and Metformin 500mg to improve blood sugar control in type 2 diabetes. Main uses: adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; helps lower raised blood sugar as part of a diabetes management plan; used when diet and exercise alone do not bring blood sugar to the desired level.

Common side effects of Sitavib M 500 Tablet include diarrhoea; upper respiratory tract infection; nasopharyngitis (inflammation of the nose and throat); headache; nausea or vomiting; flatulence or stomach discomfort. Get medical help at once if you notice lactic acidosis (rare but serious build-up of lactic acid; symptoms include weakness, muscle pain, breathing difficulty, sleepiness and abdominal pain); pancreatitis (severe pain in the abdomen that may spread to the back); serious allergic reactions including anaphylaxis and swelling of the face or throat (angioedema).

Each Sitavib M 500 tablet contains Sitagliptin Phosphate 50 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Sitavib M 500 Tablet only as your doctor advises.

The MRP of Sitavib M 500 Tablet is ₹154 for a pack of 2x15 (Blister). For chemists and distributors, the PTR is ₹117.33 and the PTS is ₹105.6.

Each Sitavib M 500 tablet contains Sitagliptin Phosphate 50 mg + Metformin 500 mg. It comes in a pack of 2x15 (Blister).

Sitagliptin Phosphate slows the breakdown of incretin hormones released by the intestine after meals, so the pancreas is supported to release insulin and blood sugar rises less after eating. Metformin reduces the sugar produced by the liver and helps the body respond to its own insulin. The two ingredients work in different ways to improve glycemic control.

Must not be used in patients with severe kidney impairment (eGFR below 30 mL/min/1.73 m2). Must not be used in patients with metabolic acidosis, including diabetic ketoacidosis. Must not be used by anyone with a history of a serious allergy to sitagliptin, metformin or any tablet ingredient, such as anaphylaxis or angioedema. Must not be used in patients with type 1 diabetes mellitus. Check with a doctor first if you have kidney or liver problems, risk factors for heart failure, a history of pancreatitis, drink alcohol heavily, are 65 years or older, or are scheduled for a scan with contrast dye or surgery.

Sitavib M 500 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.